ライフサイエンスコーパス: hospital-acquired infection

1 ry tract infections (caUTI), the most common hospital acquired infection.

2 teria that have emerged as leading causes of hospital-acquired infection.

3 ylococcus aureus is the most common cause of hospital-acquired infection.

4 ding causes of multiple antibiotic-resistant hospital-acquired infection.

5 e, and are now recognized as major agents of hospital-acquired infection.

6 ading causes of highly antibiotic-resistant, hospital-acquired infection.

7 ed pneumonia (NV-HAP) is a common and deadly hospital-acquired infection.

8 l disease and in both community-acquired and hospital-acquired infection.

9 Impaired neutrophil phagocytosis predicts hospital-acquired infection.

10 uals exposed to index case patients with non-hospital-acquired infection.

11 sistant Staphylococcus aureus as the primary hospital-acquired infection.

12 are vigorously focusing on reducing rates of hospital-acquired infection.

13 Clostridium difficile is a leading hospital-acquired infection.

14 ne of the most important causative agents of hospital acquired infections.

15 complications such as stunned myocardium and hospital acquired infections.

16 ract, skin, blood and circulatory system, or hospital acquired infections.

17 an pathogen involved in antibiotic-resistant hospital acquired infections.

18 tinal domination by bacteria associated with hospital-acquired infections.

19 aeruginosa has emerged as a major source of hospital-acquired infections.

20 ium Pseudomonas aeruginosa frequently causes hospital-acquired infections.

21 creased compliance with practices to prevent hospital-acquired infections.

22 ic-resistant enterococci are major causes of hospital-acquired infections.

23 ents may be a vector for the transmission of hospital-acquired infections.

24 ential element of public health planning for hospital-acquired infections.

25 otential reservoirs for either community- or hospital-acquired infections.

26 individuals with community-acquired (CA) and hospital-acquired infections.

27 us epidermidis, are the predominant cause of hospital-acquired infections.

28 eat difficulties in the treatment of serious hospital-acquired infections.

29 in cost and patient morbidity attributed to hospital-acquired infections.

30 Enterococci are an important cause of hospital-acquired infections.

31 Biofilm infections are major hospital-acquired infections.

32 normal human commensals and major causes of hospital-acquired infections.

33 Hand hygiene (HH) is essential to prevent hospital-acquired infections.

34 ly C. albicans, which is a leading source of hospital-acquired infections.

35 human health, particularly in the context of hospital-acquired infections.

36 an opportunistic pathogen and major cause of hospital-acquired infections.

37 taphylococcus aureus is the leading cause of hospital-acquired infections.

38 play a role in inequitable hospital care for hospital-acquired infections.

39 rococcus faecium (VRE) is a leading cause of hospital-acquired infections.

40 ycin-resistant E. faecium, which causes many hospital-acquired infections.

41 stant enterococci (VRE) are a major cause of hospital-acquired infections.

42 re vulnerable to secondary problems, such as hospital-acquired infections.

43 sistant bacteria and is the leading cause of hospital-acquired infections.

44 ue infections, bone and joint infections and hospital-acquired infections.

45 onal procedures, adverse drug reactions, and hospital-acquired infections.

46 ical for optimal treatment and prevention of hospital-acquired infections.

47 procedures place them at increased risk for hospital-acquired infections.

48 ngs that has recently emerged as a source of hospital-acquired infections.

49 s are a frequent source of life-threatening, hospital-acquired infections.

50 a bacterial pathogen of rising importance in hospital-acquired infections.

51 he most successful pathogens responsible for hospital-acquired infections.

52 astrointestinal tract and a leading cause of hospital-acquired infections.

53 countermeasure to decrease the prevalence of hospital-acquired infections.

54 most common fungal pathogen responsible for hospital-acquired infections.

55 uman pathogen, is a frequent cause of severe hospital-acquired infections.

56 en Enterococcus faecalis, a leading cause of hospital-acquired infections.

57 ff, shorter hospital stays, and avoidance of hospital-acquired infections.

58 hey are causative agents of life-threatening hospital-acquired infections.

59 odel to quantify key elements in nosocomial (hospital-acquired) infections.

60 terococcus faecium (VRE), a leading cause of hospital-acquired infections(1,2).

61 a (11 and 7 patients, respectively), and new hospital-acquired infection (13 and 12 patients, respect

62 It is a major cause of hospital-acquired infection; a large number of those exp

63 ary tract infection (CAUTI) is the commonest hospital-acquired infection, accounting for over 100,000

64 adverse event domains: adverse drug events, hospital-acquired infections, adverse events after a pro

65 e high risk of opportunistic, community, and hospital-acquired infections, all of which can lead to s

66 increased for most pathogens associated with hospital-acquired infections among ICU patients, and rat

67 nnii is a significant cause of opportunistic hospital acquired infection and has been identified as a

68 pore-forming anaerobe and a leading cause of hospital-acquired infection and gastroenteritis-associat

69 ) represents the second most common cause of hospital-acquired infection and the most common type of

70 roup of bacteria that are a leading cause of hospital-acquired infections and a major concern in term

71 responsible for manifold problems, including hospital-acquired infections and biofouling, but they ca

72 demonstrate how infectious agents following hospital-acquired infections and consequent antibiotic r

73 onstrate this strategy's potential to combat hospital-acquired infections and contribute to fighting

74 one of the most common etiological agents in hospital-acquired infections and food-borne illness.

75 eruginosa have become a concerning threat in hospital-acquired infections and for cystic fibrosis pat

76 urinary tract infections (CAUTIs) are common hospital-acquired infections and frequently polymicrobia

77 ces as well as increased patient exposure to hospital-acquired infections and functional decline.

78 The frequencies of hospital-acquired infections and gastrointestinal bleedi

79 g-resistant A. baumannii is a major cause of hospital-acquired infections and has been recognised by

80 Enterococci are major contributors of hospital-acquired infections and have emerged as importa

81 trating their potential as a tool to control hospital-acquired infections and help direct surveillanc

82 gen, causes acute pneumonia in patients with hospital-acquired infections and is commonly associated

83 Pseudomonas aeruginosa is a leading cause of hospital-acquired infections and is resistant to many an

84 Increasing antibiotic resistant hospital-acquired infections and limited new antibiotic

85 or obese was associated with higher risk of hospital-acquired infections and lower likelihood of hos

86 etiology of infection and for community- and hospital-acquired infections and occurred despite a lowe

87 Klebsiella pneumoniae is infamous for hospital-acquired infections and sepsis, which have also

88 idium) difficile is the most common cause of hospital-acquired infection, and advanced age is a risk

89 ng for age, history of pneumonia, history of hospital-acquired infection, and history of sepsis.

90 , age, sex, comorbidities, community- versus hospital-acquired infection, and organism type.

91 respiratory failure, venous thromboembolism, hospital-acquired infection, and surgical procedure-rela

92 nts with sepsis at admission who developed a hospital-acquired infection, and those who received a lo

93 Pseudomonas aeruginosa is a major agent of hospital-acquired infections, and a pathogen of immunoco

94 all patient groups for adverse drug events, hospital-acquired infections, and general adverse events

95 Hospital-acquired infections are a global health problem

96 Hospital-acquired infections are an increasingly serious

97 Nosocomial, or hospital-acquired, infections are a key determinant of p

98 es from patients with confirmed or suspected hospital-acquired infections, as well as isolates obtain

99 valuated the performance of a new NGS assay (Hospital Acquired Infection BioDetection System; Pathoge

100 a is associated with increased mortality and hospital-acquired infection, but the evidence relates ma

101 main one of the few valid treatments against hospital-acquired infections by Gram-negative bacteria.

102 Hospital-acquired infections caused by antibiotic-resist

103 study was performed to assess the impact of hospital-acquired infections caused by MDROs on morbidit

104 Hospital-acquired infections, caused by ESKAPE bacteria,

105 y, shorter hospital length of stay, and less hospital-acquired infections compared with tocilizumab.

106 enomic sequence in the two of the cases with hospital-acquired infection, consistent with the concern

107 gth of stay, rates of facial and limb edema, hospital-acquired infections, device displacement, and m

108 ,122 of 45,209 (43%) deaths in patients with hospital-acquired infection due to MDR bacteria in Thail

109 Hospital-acquired infection due to meticillin-resistant

110 The national impact on hospital-acquired infections due to other organisms has

111 Enterococcus faecalis, a leading cause of hospital-acquired infections, exhibits intrinsic resista

112 tilator-associated pneumonia (VAP), a severe hospital-acquired infection for significant mortality.

113 Pseudomonas aeruginosa is a leading cause of hospital-acquired infections for which the development o

114 ae (ESBL-Kp) are among the leading causes of hospital-acquired infections globally.

115 of two most common pathogens responsible for hospital acquired infections: gram-positive Staphylococc

116 The performance of the hospital-acquired infection (HAI) BioDetection System fo

117 ing healthcare debate is whether controlling hospital-acquired infection (HAI) from methicillin-resis

118 Little is known regarding the impact of hospital-acquired infection (HAI) in acute pancreatitis

119 -associated pneumonia (VAP) is the commonest hospital-acquired infection (HAI) in intensive care.

120 Hospital-acquired infections (HAI) resulting from the tr

121 Hospital acquired infections (HAIs) and the emergence of

122 del using published data on the rate of MRSA hospital-acquired infections (HAIs) and HO-GNR bacteremi

123 ococci (VRE) are the second leading cause of hospital-acquired infections (HAIs) attributed to a drug

124 Pathogens typically responsible for hospital-acquired infections (HAIs) constitute a major t

125 Postoperative hospital-acquired infections (HAIs) may result from disr

126 Point prevalence surveys for hospital-acquired infections (HAIs) were conducted weekl

127 ackle growing antibiotic resistance (AR) and hospital-acquired infections (HAIs), novel antimicrobial

128 s, and on the incidence of probable/definite hospital-acquired infections (HAIs), was evaluated.

129 tract infections (CAUTIs) account for 40% of hospital-acquired infections (HAIs).

130 smission of VRE and aid in the prevention of hospital-acquired infections (HAIs).

131 Mortality was increased in hospital-acquired infection (hospital, 17/36 [47%]; comm

132 ting resistance in community-acquired versus hospital-acquired infections, implementation of standard

133 help hospitals reap the benefits of reduced hospital-acquired infections, improved patient recovery,

134 erales (CPE), traditionally thought to cause hospital-acquired infection in humans, are now emerging

135 is of seven studies showed increased odds of hospital-acquired infection in people treated with corti

136 difficile infection (CDI) is the number one hospital-acquired infection in the United States.

137 ity-acquired infections in humans as well as hospital-acquired infections in pets.

138 decreasing the rates of intensive care unit hospital-acquired infections in the past decade.

139 (SSI) are one of the most common and costly hospital-acquired infections in the United States.

140 ne of the most common bacterial pathogens in hospital-acquired infections in the United States.

141 difficile is currently the leading cause of hospital-acquired infections in the United States.

142 A), a Gram-negative bacteria associated with hospital-acquired infections, in different conformations

143 Approximately 60% of hospital-acquired infections included bacteria frequentl

144 Influenza is an important cause of viral hospital-acquired infection involving patients, healthca

145 forts to prevent complications stemming from hospital-acquired infection is commendable, these effort

146 easing frequency of antibiotic resistance in hospital-acquired infections is a major public health co

147 One strategy to decrease the incidence of hospital-acquired infections is to avoid the survival of

148 f) is one of the most common and most severe hospital-acquired infections; its consequences range fro

149 ody mass index z score, to 60-day mortality, hospital-acquired infections, length of hospital stay, a

150 Bacteria that cause most of the hospital-acquired infections make use of class C beta-la

151 ltiplex detection of sequences relating to a hospital-acquired infection, namely, methicillin-resista

152 ed on matching patient encounters in which a hospital-acquired infection occurred to comparable encou

153 ibiotics against S. aureus, particularly for hospital-acquired infections, offering a promising avenu

154 ceived susceptibility and severity towards a hospital-acquired infection or a misidentification error

155 th sepsis at admission and did not develop a hospital-acquired infection or those who presented witho

156 linical isolates obtained from patients with hospital-acquired infections or with cystic fibrosis.

157 0.92; 95% CI, 0.90-0.94) and lower rates of hospital-acquired infections (OR, 0.86; 95% CI, 0.75-0.9

158 Hospital-acquired infections other than central line-ass

159 ngs demonstrate the potential for 2 types of hospital-acquired infection outbreaks: those due to clon

160 al adhesion to medical devices is common for hospital-acquired infections, particularly for urinary c

161 al decision support algorithm for predicting hospital-acquired infection (predating COVID-19) could b

162 icacy of public health interventions such as hospital acquired infection prevention, antimicrobial st

163 Hospital-acquired infection rates were not different bet

164 s morbidity (hospital-acquired and resistant hospital-acquired infection rates) on the non-ICU wards

165 Of all CDI, hospital-acquired infection remains more common.

166 However, OmpA clinical implication in hospital-acquired infections remains unknown.

167 mechanical ventilation, Pa o2 /F io2 ratio, hospital-acquired infections, renal replacement therapy,

168 acute respiratory distress syndrome, shock, hospital-acquired infections, renal replacement therapy,

169 As one of the leading causes of hospital-acquired infections reported by the National He

170 gn of novel therapeutics that combat severe, hospital-acquired infections resistant to the establishe

171 um difficile infection (CDI) is an important hospital-acquired infection resulting from the germinati

172 n their index admission who also developed a hospital-acquired infection ("second hit") were nearly t

173 Rates of hospital-acquired infections, specifically methicillin-r

174 Enterococci commonly cause hospital-acquired infections, such as infective endocard

175 ial control measures are typically faster in hospital-acquired infections than in community-acquired

176 hylococcus aureus (MRSA) is a major cause of hospital-acquired infections that are becoming increasin

177 However, as shown in the recent reduction in hospital acquired infections, the number of deaths could

178 year about 400,000 patients die from sepsis, hospital acquired infections, venous thromboembolism, an

179 The absolute risk reduction for acquiring a hospital-acquired infection was 9.0% (95% CI, 1.5-16.4%;

180 ter versus chlorhexidine, counts of incident hospital-acquired infections were 14 versus 7 for cathet

181 The odds of hospital-acquired infections were higher in underweight

182 Septic shock and hospital-acquired infections were predictors of treatmen

183 Hospital-acquired infections were reduced by 50%.

184 Of these patients, 407 hospital-acquired infections were treated during the non

185 cinetobacter baumannii is a leading cause of hospital-acquired infections, where outbreaks are driven

186 species are responsible for the majority of hospital-acquired infections, which are often complicate

187 ere common among human carriage isolates and hospital-acquired infections, which generally lacked the

188 time of infection exaggerated the impact of hospital-acquired infections with regard to attributed l

189 Recently, an increased incidence of hospital-acquired infections with severe outcomes has be

190 ance quality-improvement efforts to minimize hospital-acquired infections with VRE.

191 dioides difficile remains a leading cause of hospital-acquired infections, with its primary virulence

192 adult patients with low-risk SAB, defined as hospital-acquired infection without treatment delay, abs

193 ommon cause of severe community-acquired and hospital-acquired infection worldwide.

194 ract infections (CaUTIs) are the most common hospital-acquired infections worldwide and are frequentl

195 inetobacter baumannii is a frequent cause of hospital-acquired infections worldwide and is a challeng

196 cus aureus is the leading cause of wound and hospital-acquired infections worldwide.